PARTICLE THERAPY COOPERATIVE GROUP… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2013

Legal Domicile

Principal Officer

MATTHEW HALL

Phone

6189108157

Tax Period

2023-01-01 to 2023-12-31

PARTICLE THERAPY COOPERATIVE GROUP-NORTH AMERICA INC, founded in 2013, is a small nonprofit in the Medical Research sector that reported $110K in total revenue in fiscal year 2023. Revenue fell 88% from the prior year — a significant decline worth monitoring. Expenses of $188K exceeded revenue, resulting in a 71% operating deficit.

Mission

TO PROVIDE CONTINUING MEDICAL EDUCATION, ENGAGE IN SCIENTIFIC RESEARCH AND PARTICIPATE IN CLINICAL STUDIES AND ENGAGE IN PATIENT ADVOCACY ACTIVITIES RELATED TO PARTICLE THERAPY.

Program Service Accomplishments

Program 1

Expenses: $184,179 Revenue: $109,827

TO PROVIDE CONTINUING MEDICAL EDUCATION, ENGAGE IN SCIENTIFIC RESEARCH AND PARTICIPATE IN CLINICAL STUDIES AND ENGAGE IN PATIENT ADVOCACY ACTIVITIES RELATED TO PARTICLE THERAPY.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $109,827

Investment Income $0

Other Revenue $0

TOTAL REVENUE $109,827

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $184,179

Other Expenses $187,688

TOTAL EXPENSES $187,688

Year-over-Year Comparison

	2023	2022	Change
Revenue	$109,827	$933,302	-0.9%
Expenses	$187,688	$841,096	-0.8%
Net Income	$-77,861	$92,206	-1.8%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JULIE BRADLEY	VICE-PRESIDENT	2.00	Officer Director	$0	$0	$0
ANITA MAHAJAN MD	PRESIDENT	5.00	Officer	$0	$0	$0
MATTHEW HALL	TREASURER	2.00	Officer	$0	$0	$0
BRADFORD HOPPE	SECRETARY	5.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2023	$109,827	$187,688	$213,163	$-77,861
2022	$933,302	$841,096	$291,024	$92,206

PARTICLE THERAPY COOPERATIVE GROUP-NORTH AMERICA INC